These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Axon-Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter. Luchicchi A; Hart B; Frigerio I; van Dam AM; Perna L; Offerhaus HL; Stys PK; Schenk GJ; Geurts JJG Ann Neurol; 2021 Apr; 89(4):711-725. PubMed ID: 33410190 [TBL] [Abstract][Full Text] [Related]
24. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356 [TBL] [Abstract][Full Text] [Related]
25. Remyelination and restoration of axonal function by glial cell transplantation. Duncan ID Ernst Schering Res Found Workshop; 2005; (53):115-32. PubMed ID: 16315611 [No Abstract] [Full Text] [Related]
27. Roads to Formation of Normal Myelin Structure and Pathological Myelin Structure. Bando Y Adv Exp Med Biol; 2019; 1190():257-264. PubMed ID: 31760649 [TBL] [Abstract][Full Text] [Related]
29. Axonal damage in multiple sclerosis. Haines JD; Inglese M; Casaccia P Mt Sinai J Med; 2011; 78(2):231-43. PubMed ID: 21425267 [TBL] [Abstract][Full Text] [Related]
30. Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease. Schäffner E; Bosch-Queralt M; Edgar JM; Lehning M; Strauß J; Fleischer N; Kungl T; Wieghofer P; Berghoff SA; Reinert T; Krueger M; Morawski M; Möbius W; Barrantes-Freer A; Stieler J; Sun T; Saher G; Schwab MH; Wrede C; Frosch M; Prinz M; Reich DS; Flügel A; Stadelmann C; Fledrich R; Nave KA; Stassart RM Nat Neurosci; 2023 Jul; 26(7):1218-1228. PubMed ID: 37386131 [TBL] [Abstract][Full Text] [Related]
31. Influence of neurosteroids on the pathogenesis of multiple sclerosis. Leitner H Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191 [TBL] [Abstract][Full Text] [Related]
32. Axonal loss in multiple sclerosis: causes and mechanisms. Criste G; Trapp B; Dutta R Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515 [TBL] [Abstract][Full Text] [Related]
33. Axonal transection in the lesions of multiple sclerosis. Trapp BD; Peterson J; Ransohoff RM; Rudick R; Mörk S; Bö L N Engl J Med; 1998 Jan; 338(5):278-85. PubMed ID: 9445407 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis. Brück W J Neurol; 2005 Nov; 252 Suppl 5():v10-5. PubMed ID: 16254696 [TBL] [Abstract][Full Text] [Related]
35. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system. Miller DJ; Asakura K; Rodriguez M J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222 [TBL] [Abstract][Full Text] [Related]
36. Promoting myelin repair and return of function in multiple sclerosis. Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535 [TBL] [Abstract][Full Text] [Related]
38. [Promoting myelin repair in disorders such as multiple sclerosis and some types of leukodystrophy: current studies]. Baron-Van Evercooren A; Lachapelle F; Nait-Oumesmar B; Pham-Dinh D Rev Neurol (Paris); 2007 May; 163(5):523-31. PubMed ID: 17571021 [TBL] [Abstract][Full Text] [Related]
39. Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination. Staugaitis SM; Chang A; Trapp BD Acta Neurol Scand Suppl; 2012; (195):97-102. PubMed ID: 23278664 [TBL] [Abstract][Full Text] [Related]
40. The neuropathology of multiple sclerosis. Ludwin SK Neuroimaging Clin N Am; 2000 Nov; 10(4):625-48 ,vii. PubMed ID: 11359716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]